Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Amplify Weight Loss Drug & Treatment ETF THNR

Set alert

25.92 USD -0.02 -0.09%

As of Nov 2, 11:41 AM ET

Bid: 25.93 × 200
Ask: 26.01 × 200

25.92 Day range 25.92

23.16 52-week range 27.94

YTD: +2.79%
1 year: +11.25%

Open: 25.92
Prev close: 25.95
Mkt cap: 5.97M
Vol: 168
Avg vol: 1.26K
EPS: 1.22
P/E: 21.27
Div yield: 0.00%

More statistics

Low: 25.92
High: 25.92
Forward P/E: 0.00
Beta: 0.00
Short ratio: 0.00
Dividend: 0.00
Ex-div date
50-d avg: 24.63
200-d avg: 25.88

Chart tools

Interval

Chart is warming up

The five-day price history for THNR has not been loaded yet. Try again in a moment.

Issuer: Amplify
Asset class: Equity
Expense ratio: 0.59%
Assets under management: $5.97M
NAV: 25.95
Holdings: 20
Inception: 2024-05-21
Top 10 weight: 66.46%

LLY Eli Lilly & Co 11.95%
NVO Novo Nordisk A/S 8.60%
AMGN Amgen Inc 6.15%
REGN Regeneron Pharmaceuticals Inc 5.91%
AZN AstraZeneca PLC 5.91%
ROP.SW Roche Holding AG 5.82%
GILD Gilead Sciences Inc 5.79%
ABBV AbbVie Inc 5.68%
PFE Pfizer Inc 5.57%
4519.T Chugai Pharmaceutical Co Ltd 5.08%
MRK Merck & Co Inc 5.07%
1093.HK CSPC Pharmaceutical Group Ltd 4.40%
1801.HK Innovent Biologics Inc 4.17%
VKTX Viking Therapeutics Inc 4.17%
ARWR Arrowhead Pharmaceuticals Inc 3.55%
ZEAL.CO Zealand Pharma A/S 3.25%
128940.KS Hanmi Pharm Co Ltd 2.88%
1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd 2.32%
GPCR Structure Therapeutics Inc 2.23%
KLRA Kailera Therapeutics Inc 1.07%
AGPXX Invesco Government & Agency Portfolio 12/31/2031 0.24%
Cash & Other 0.18%

Healthcare 99.55%
Financial Services 0.26%
Cash & Others 0.19%

United States 57.17%
Denmark 11.97%
China 11.40%
Switzerland 5.93%
United Kingdom 5.68%
Japan 5.09%
South Korea 2.77%

Updated 2026-11-03